Life Science leaders applying high performance computing (HPC) to their R&D pipelines, are exploiting the advantages of new cloud infrastructures for their simulations. The urgency and complexity of navigating discovery, production, and approval processes has pushed fixed HPC infrastructure to its limits. Now leading companies are looking for new ways to enhance their simulation capabilities by leveraging dynamic cloud resources to boost agility, collaboration, and most importantly the safety and efficacy of new treatments.